Clinical Trial Update: Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of SyB L-0501 in patients with Chronic Lymphocytic Leukemia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• SyB L-0501

Snippet

Sponsor: SymBio Pharmaceuticals | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2016-03-29